Merck Sharp & Dohme Corporation, Petitioner v. Doris Albrecht, et al.
Case Number:
24-977
Court:
Nature of Suit:
4365 Personal Injury-Product Liability
Firms
Companies
- Merck & Co. Inc.
- Pharmaceutical Research & Manufacturers of America
- Product Liability Advisory Council Inc.
- Washington Legal Foundation
Sectors & Industries:
-
June 16, 2025
Justices Turn Away Merck's Bone Drug Warning Label Row
The U.S. Supreme Court on Monday rejected Merck Sharp & Dohme Corp.'s request to review a Third Circuit decision that more than 1,000 failure-to-warn claims over its osteoporosis drug Fosamax can continue despite the company's assertion that the litigation is barred by federal law.
-
March 13, 2025
Merck Asks Justices To Block Fosamax Failure-To-Warn Suits
Merck has asked the U.S. Supreme Court to review a Third Circuit ruling that allowed more than 1,000 state-law failure-to-warn claims over its osteoporosis drug Fosamax, arguing that the U.S. Food and Drug Administration's formal rejection of a such a proposed warning label should block such lawsuits under federal law.